LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
24h
Current
Min
7.65
Max
8.19
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +158.94% upside |
Next Earnings | 10 lis 2025 |
---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
27 lis 2024, 13:34 UTC
CervoMed Shares Rise 15% on FDA's Orphan Drug Designation for Neflamapimod
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 21 USD 158.94%
High 31 USD
Low 11 USD
Based on 5 Wall Street analysts offering 12 month price targets forCervoMed Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
5 ratings
4
Buy
1
Hold
0
Sell
Based on 5 analysts giving stock ratings to CervoMed Inc - Dist in the past 3 months.
$